Know a great AI tool or AI news source? Submit it to AiByts
Ars Technica1 min read

The FDA wants to pull its approval of a drug. It’s not so easy.

The regulator says Tavneos was approved on the basis of manipulated study data. Should patients still have access to it?

By Sara Talpos, Undark MagazineArs Technica
The FDA wants to pull its approval of a drug. It’s not so easy.

Read the full story

Originally published by Ars Technica on Oct 31, 2026.

Read on Ars Technica(opens in a new tab)

Comments

Sign in to join the discussion.

No comments yet — be the first to share your thoughts.